A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine, and waiting until they are tested in longer clinical trials?
Dr. Derek Angus, professor and chair of the Department of Critical Care Medicine at Pitt and UPMC, explained the trial at a live press briefing today.
Dr. Donald Yealy, professor and chair of the Department of Emergency Medicine at Pitt and UPMC, also updated the public on UPMC’s COVID-19 testing and hospitalizations systemwide.
UPMC will be regularly updating the community on this developing situation. Follow UPMC News for updates.